Manager Indirect Tax Compliance
Amgen
Manager Indirect Tax Compliance
Amgen
Makes biotech medicines for serious illnesses
Join Amgen’s Mission of Serving Patients
At Amgen, if you feel like you are part of something bigger, it’s because you are. Our shared mission - to serve patients living with serious illnesses - drives all that we do.
Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas - Oncology, Inflammation, General Medicine, and Rare Disease - we reach millions of patients each year. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.
Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.
Manager Indirect Tax Compliance
What you will do
Let’s do this. Let’s change the world. For this new role, we are seeking an Indirect Tax Compliance Manager to assist establishing a Center of Excellence (CoE) focused on VAT and GST compliance across multiple regions and managing Amgen’s VAT/GST compliance. This role is pivotal in shaping the future of indirect tax operations and driving compliance efficiency.
The successful candidate will be a strong team player with a passion for technology, automation, and process excellence.
Responsibilities
As Manager Indirect Tax Compliance you will be reporting to the Senior Manager Indirect Tax Compliance.
Outputs
Qualifications
The knowledge and skills necessary to perform the duties of this position are typically acquired through the following combination of education, experience and knowledge, or the equivalent.
Minimum Requirements
Preferred Requirements
Competencies
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen